Treating Advanced Squamous Non-Small Cell Lung Cancer

EP. 1: Clinical Presentation of Squamous NSCLC

March 3rd 2016

EP. 2: Mutational Landscape of Squamous NSCLC

March 3rd 2016

EP. 3: Mutation Testing and Lung-MAP Clinical Trial

March 3rd 2016

EP. 4: Optimal Chemotherapy for Squamous NSCLC

March 3rd 2016

EP. 5: Nab-Paclitaxel plus Carboplatin in Squamous NSCLC

March 3rd 2016

EP. 6: Maintenance Therapy in Squamous NSCLC

March 3rd 2016

EP. 7: Treatment Options for Relapsed Squamous NSCLC

March 3rd 2016

EP. 8: Monoclonal Antibodies in Squamous Cell Lung Cancer

March 3rd 2016

EP. 9: Clinical Trial Results of Ramucirumab in Squamous NSCLC

March 3rd 2016

EP. 10: Immune Checkpoint Inhibitors in Squamous Non-Small Cell Lung Cancer

March 3rd 2016

EP. 11: PD-L1 as a Biomarker in Squamous Non-Small Cell Lung Cancer

March 3rd 2016

EP. 12: Safety of PD-1 Inhibitors in Squamous NSCLC

March 3rd 2016

EP. 13: Ipilimumab in Squamous Non-Small Cell Lung Cancer

March 3rd 2016

EP. 14: TKIs in Squamous NSCLC: LUX-Lung-8

March 3rd 2016

EP. 15: Optimal Sequencing in Squamous Non-Small Cell Lung Cancer

March 3rd 2016